Steltzer H, Hiesmayr M, Tüchy G, Zimpfer M
Universitätsklinik für Anästhesie und allgemeine Intensivmedizin, Wien.
Anaesthesist. 1992 Aug;41(8):457-62.
The relationship between oxygen consumption (VO2) and oxygen delivery (DO2) is of interest in critically ill patients. Various studies of these parameters have resulted in different concepts for optimizing DO2 and VO2. During liver transplantation without anhepatic veno-venous bypass, caval cross-clamping initiates a series of haemodynamic and metabolic alterations including the rapid change from hyperdynamic to hypodynamic conditions. In addition, simultaneous changes in DO2 and VO2 occur in these patients. The goal of our present study was to test the clinical relevance of therapeutic interventions based on metabolic monitoring in patients with terminal liver disease undergoing orthotopic liver transplantation. PATIENTS AND METHODS. One hundred sixty-two consecutive patients were evaluated. According to outcome, patients were divided into survivors (n = 115, group A), nonsurvivors (n = 30, group B), and patients with primary nonfunction of the liver graft (n = 17, group C). One hundred twenty patients were cirrhotics due to either alcohol (n = 36), aggressive hepatitis (n = 30), or biliary cirrhosis (n = 54); 42 had a neoplastic disease. Haemodynamic measurements, data for calculations of DO2 and VO2, and blood samples for arterial and mixed-venous blood gases and subsequent laboratory analysis were taken during the surgical procedure at six timepoints: after induction of anaesthesia (I); during preparation of the recipient liver, before cross-clamping (II); 10 min after clamping of the inferior vena cava (III); 10 min before unclamping (IV); with all vessels open, 10 min after declamping during reperfusion (V); and 60 min after declamping (VI). Anaesthesia was induced with thiopentone (3-5 mg/kg i.v.) and fentanyl (15 micrograms/kg min i.v.). Muscle relaxation was achieved with pancuronium (0.1 mg/kg i.v.). Anaesthesia was maintained with i.v. supplements of fentanyl (5-10 micrograms/kg) and pancuronium (4 mg) as required. Volume-cycled ventilation was established with a mixture of O2 in air with a positive end-expiratory pressure of 5 mm H2O to keep the PaO2 above 100 mm Hg and the PaCO2 around 35 mm Hg (Servo 900 C-Ventilator, Siemens). To maintain body temperature, all patients were positioned on a heating blanket set at 38 degrees C. The inspired gases were warmed and humidified using a dual servo-heated humidifier. Mannitol (20-40 g i.v.) or sorbitol (16-24 g i.v.) was given to prevent renal dysfunction during the cross-clamping procedure. Lactated Ringer's solution and fresh frozen plasma administration was guided by cardiovascular performance and requirements for clotting factors, respectively. Cardiac output was measured by the thermodilution method using a pulmonary artery catheter. Blood lactate, haemoglobin concentration, arterial and mixed-venous oxygen content, and oxygen saturation were measured (Hemoxymeter OSM3). VO2 and DO2 were calculated according to standard formulas. STATISTICAL ANALYSIS. The data from groups A, B, and C were compared using a multivariate analysis of variance with Tukey's method for multiple comparisons. A least-square regression was used to correlate metabolic data. RESULTS. The perioperative course of the determinants of oxygen transport is shown in Table 1. After cross-clamping, the cardiac index (CI) decreased in groups A (47%), B (53%), and C (51%) and increased to pre-anhepatic levels after reperfusion of the new liver. This was associated with distinct decreases in DO2 (A: 42%, B: 47%, and C: 45%) and VO2 (A: 8%, B: 19%, C: 25%). After reperfusion of the new allograft (V), VO2 increased in groups A (24%) and B (18%) as compared to controls (I). By contrast, in group C, a distinct further decrease in VO2 (13%) was detected. In these patients, there was a significantly greater increase in mixed-venous saturation accompanied by a further decrease in body temperature. As shown in Figures 1 and 2, no significant relationship was found between O2 transport, VO2, and blood lactate. DISC
氧耗量(VO2)与氧输送(DO2)之间的关系在危重症患者中备受关注。对这些参数的各种研究产生了关于优化DO2和VO2的不同概念。在无肝静脉 - 静脉转流的肝移植过程中,腔静脉阻断引发了一系列血流动力学和代谢改变,包括从高动力状态迅速转变为低动力状态。此外,这些患者的DO2和VO2会同时发生变化。我们当前研究的目的是测试基于代谢监测的治疗干预措施对终末期肝病患者进行原位肝移植的临床相关性。患者与方法。连续评估了162例患者。根据预后情况,患者被分为幸存者(n = 115,A组)、非幸存者(n = 30,B组)和肝移植原发性无功能患者(n = 17,C组)。120例患者为肝硬化患者,病因分别为酒精性(n = 36)、侵袭性肝炎(n = 30)或胆汁性肝硬化(n = 54);42例患有肿瘤性疾病。在手术过程中的六个时间点进行血流动力学测量、用于计算DO2和VO2的数据采集以及采集动脉血和混合静脉血样本进行血气分析及后续实验室分析:麻醉诱导后(I);在受体肝脏准备期间,腔静脉阻断前(II);下腔静脉阻断10分钟后(III);阻断解除前10分钟(IV);所有血管开放,再灌注期间阻断解除10分钟后(V);阻断解除60分钟后(VI)。用硫喷妥钠(3 - 5mg/kg静脉注射)和芬太尼(15μg/kg静脉注射)诱导麻醉。用潘库溴铵(0.1mg/kg静脉注射)实现肌肉松弛。根据需要用静脉补充芬太尼(5 - 10μg/kg)和潘库溴铵(4mg)维持麻醉。采用空气与氧气混合、呼气末正压为5mmHg的容量控制通气,以使动脉血氧分压(PaO2)保持在100mmHg以上,动脉血二氧化碳分压(PaCO2)维持在35mmHg左右(西门子Servo 900 C型呼吸机)。为维持体温,所有患者置于温度设定为38℃的加热毯上。使用双伺服加热加湿器对吸入气体进行加温和加湿。在腔静脉阻断过程中给予甘露醇(20 - 40g静脉注射)或山梨醇(16 - 24g静脉注射)以预防肾功能障碍。乳酸林格氏液和新鲜冰冻血浆的输注分别根据心血管功能和凝血因子需求进行指导。使用肺动脉导管通过热稀释法测量心输出量。测量血乳酸、血红蛋白浓度、动脉血和混合静脉血氧含量以及血氧饱和度(OSM3型血氧仪)。根据标准公式计算VO2和DO2。统计分析。使用方差分析及Tukey多重比较方法对A、B和C组的数据进行比较。采用最小二乘法回归分析代谢数据之间的相关性。结果。氧输送决定因素的围手术期过程见表1。腔静脉阻断后,A组(47%)、B组(53%)和C组(51%)的心指数(CI)下降,新肝再灌注后回升至无肝前期水平。这与DO2(A组:42%,B组:47%,C组:45%)和VO2(A组:8%,B组:19%,C组:25%)的明显下降相关。新移植肝再灌注后(V),与对照组(I)相比,A组(24%)和B组(18%)的VO2升高。相比之下,在C组中,VO2出现明显进一步下降(13%)。在这些患者中,混合静脉血氧饱和度显著升高,同时体温进一步下降。如图1和图2所示,未发现氧输送(O2 transport)、VO2与血乳酸之间存在显著关系。DISC